These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 894449)

  • 21. Ocular bioavailability and systemic loss of topically applied ophthalmic drugs.
    Patton TF; Francoeur M
    Am J Ophthalmol; 1978 Feb; 85(2):225-9. PubMed ID: 623195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular penetration of pilocarpine: The effect of multiple doses on the ocular penetration of pilocarpine.
    Ramer RM; Gasset AR
    Ann Ophthalmol; 1975 Jan; 7(1):25-6. PubMed ID: 1111413
    [No Abstract]   [Full Text] [Related]  

  • 23. Age-related differences in ophthalmic drug disposition I. Effect of size on the intraocular tissue distribution of pilocarpine in albino rabbits.
    Miller SC; Patton TF
    Biopharm Drug Dispos; 1981; 2(3):215-33. PubMed ID: 7295879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsification.
    Bucci FA
    Am J Ophthalmol; 2004 Feb; 137(2):308-12. PubMed ID: 14962422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular penetration of pilocarpine: the effect on concentration on the ocular penetration of pilocarpine.
    Ramer RM; Gasset AR
    Ann Ophthalmol; 1974 Nov; 6(11):1160-2. PubMed ID: 4429321
    [No Abstract]   [Full Text] [Related]  

  • 27. Preliminary pharmacokinetic model of pilocarpine uptake and distribution in the eye.
    Himmelstein KJ; Guvenir I; Patton TF
    J Pharm Sci; 1978 May; 67(5):603-6. PubMed ID: 641790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The pharmacokinetics of FK506 and its nanoparticles in aqueous humor of rabbits].
    Fei WL; Chen JQ; Zhong SL; Liu YM; Pang ZQ; Wang Z; Yuan J; Ye CT
    Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):305-8. PubMed ID: 16762205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor.
    Aggarwal D; Pal D; Mitra AK; Kaur IP
    Int J Pharm; 2007 Jun; 338(1-2):21-6. PubMed ID: 17300885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular parameters related to drug delivery in the canine and equine eye: aqueous and vitreous humor volume and scleral surface area and thickness.
    Gilger BC; Reeves KA; Salmon JH
    Vet Ophthalmol; 2005; 8(4):265-9. PubMed ID: 16008707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of pilocarpine and celucarpine on ocular hemodynamics and oxygenation of the aqueous humor (experimental study)].
    Purvin'sh IV; Iakovlev AA; Konde LA; Shuster IaIa
    Vestn Oftalmol; 1975; (3):34-7. PubMed ID: 1154586
    [No Abstract]   [Full Text] [Related]  

  • 32. Chlorampenicol retention on, and penetration into, the rabbit eye.
    Green K; MacKeen DL
    Invest Ophthalmol; 1976 Mar; 15(3):220-2. PubMed ID: 1254410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative intraocular levels of pilocarpine achieved with drops and repository preparations.
    Ellis PP; Riegel MA
    J Ocul Pharmacol; 1987; 3(2):121-8. PubMed ID: 3503909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle-delivery-system.
    Zimmer A; Mutschler E; Lambrecht G; Mayer D; Kreuter J
    Pharm Res; 1994 Oct; 11(10):1435-42. PubMed ID: 7855048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Determination of three formulations of pilocarpine in rabbit ocular aqueous by RP-HPLC].
    Wang XJ; Chen B; Yao TW; Zhang HC; Zeng S
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 33(1):33-6. PubMed ID: 14966937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular evaluation of polyvinyl alcohol vehicle in rabbits.
    Patton TF; Robinson JR
    J Pharm Sci; 1975 Aug; 64(8):1312-6. PubMed ID: 1151703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simulated sustained release pilocarpine therapy and aqueous humor dynamics.
    Lerman S; Reininger B
    Can J Ophthalmol; 1971 Jan; 6(1):14-23. PubMed ID: 5546853
    [No Abstract]   [Full Text] [Related]  

  • 38. Vehicle effects on ocular drug bioavailability III: Shear-facilitated pilocarpine release from ointments.
    Sieg JW; Robinson JR
    J Pharm Sci; 1979 Jun; 68(6):724-8. PubMed ID: 458573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-related differences in ophthalmic drug disposition II: drug-protein interactions of pilocarpine and chloramphenicol.
    Miller SC; Patton TF
    Biopharm Drug Dispos; 1982; 3(2):115-28. PubMed ID: 7104461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Soluble therapeutic implants in ophthalmology (author's transl)].
    Maichuk Y
    Arch Ophtalmol (Paris); 1977; 37(8-9):545-50. PubMed ID: 145846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.